The impact of COVID-19 on managing ophthalmic diseases: an international, descriptive study.
Ir J Med Sci
; 2023 Feb 11.
Article
in English
| MEDLINE | ID: covidwho-2246134
ABSTRACT
BACKGROUND:
Anecdotally, the COVID-19 pandemic has resulted in more severe cases of eye disease, decreased medication compliance/availability, and decreased treatment volume due to the lockdown.AIMS:
We aim to quantify and bring together a variety of international perspectives from ophthalmologists of different subspecialties to characterize the global impact of COVID-19 on managing various ophthalmic disease.METHODS:
An online survey of 10 questions was conducted among ophthalmologists using a specialized survey program.RESULTS:
Fifty-two ophthalmologists were successfully contacted. Survey respondents include ophthalmologists from USA, Canada, Korea, Mexico, and New Zealand. Based on the results of our survey, 1 year after the pandemic, ophthalmic disease severity has worsened as well as a decrease in examination and medication compliance.CONCLUSIONS:
Ophthalmologists across the world have reported a general increase in disease severity and decrease in medication and examination compliance 1 year after the beginning of COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
S11845-023-03306-9
Similar
MEDLINE
...
LILACS
LIS